Principal Secretary (PS) Oluga Calls for Strategic Reforms in Kenya's Blood Transfusion and Transplant Services to Support Universal Health Coverage (UHC) Goals
During a meeting with the Kenya Blood Transfusion and Transplant Services (KBTTS) team, he stressed the importance of efficient planning, optimized supply chains, and equipment modernization to ensure safe and consistent blood availability across the country.
Dr. Oluga identified governance as a key challenge and urged the team to prioritize the public good over individual interests. He emphasized the importance of unity, accountability, and innovation to align their work with the national health agenda. He also stressed the need for strengthened policy frameworks for transplant services and the expansion of external partnerships and philanthropic support.
The PS reaffirmed the Ministry's commitment to addressing operational, human resource, and infrastructure challenges, urging the team to rethink the funding model and optimize the limited resources available to meet the sector's needs.
Significant progress has been made in the blood transfusion services, with the Directorate of Blood Transfusion and Transplant Services transitioning from whole blood to blood components in line with WHO guidance. The Directorate is also advancing blood management through the Damu-KE system, with six regional centres and full capacity across all 47 counties.
In the last financial year, the Directorate surpassed its target by collecting 449,000 units of blood and blood components. Dr. Patrick Amoth, Director General for Health, commended the team and called for an increased focus on resource mobilization, county-level partnerships, and the expediting of the Blood Transfusion Bill.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
4 hours ago
- Zawya
Roche and the African Society for Laboratory Medicine (ASLM) launch partnership to strengthen diagnostic leadership across Africa
The partnership dubbed, Leadership Excellence for African Diagnostics (LEAD) between Roche and ASLM is a three-year programme to strengthen lab leadership in Africa The initiative focuses on mentorship and training to build lab leadership capabilities Roche Diagnostics Africa ( and the African Society for Laboratory Medicine (ASLM) ( have announced the launch of a three-year partnership to elevate laboratory leadership and improve access to quality diagnostic services across the continent. The initiative — titled LEAD: Leadership Excellence for African Diagnostics — brings together health ministries, laboratory directors, academic partners and technical experts to develop a new generation of capable, connected and future-ready lab leaders. 'This partnership will build long-term leadership that would shape the future of diagnostics in Africa — practically, strategically and sustainably. In a time where we need African healthcare systems to become less reliant on external funding sources, we are focused on increasing domestic diagnostics capacity more than ever,' says Dr Allan Pamba, Executive Vice President, Diagnostics, Africa, at Roche Diagnostics. 'We are entering a new chapter where African health systems take the lead in their own transformation. By growing diagnostic leadership we support long-term resilience and impact. LEAD equips professionals who can influence policy, drive national strategy and build sustainable healthcare capacity.' Under the partnership, LEAD will deliver a series of integrated interventions including baseline leadership assessments to guide a tailored context-specific training approach, development of a pan-African curriculum in collaboration with a leading academic institution, structured mentorship and professional development for emerging lab leaders, peer learning and regional collaboration through workshops and best practise exchanges. ASLM Chief Executive Officer, Nqobile Ndlovu, added: 'Diagnostics are the foundation of resilient health systems – but strong labs require strong leaders. LEAD focuses on people: their vision, their reach and their ability to transform public health from within. With this programme, we are supporting the leadership needed to move African healthcare forward.' Roche will provide funding, technical support and global platforms for visibility while ASLM will lead country-level implementation, stakeholder coordination and curriculum development. Laboratory strengthening is a key enabler for stronger health systems and this partnership is a commitment towards a healthier future for Africans. Distributed by APO Group on behalf of Roche Diagnostics. Media queries: Precious Nkabinde Communications Lead Nelly Rwenji Communications Lead ASLM nrwenji@ About Roche: Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognising our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit All trademarks used or mentioned in this release are protected by law. About ASLM: The African Society for Laboratory Medicine (ASLM) is a pan-African organization committed to achieving a healthier Africa by increasing access to quality laboratory services for all. We work to convene and mobilize stakeholders at all levels to improve access to diagnostic services and strengthen laboratory systems and networks. Since its founding in 2011, ASLM has played a key role in advancing laboratory medicine in Africa, collaborating with partners and stakeholders to promote disease diagnosis, surveillance, and control. Through its programs and initiatives, ASLM has contributed to the development of laboratory policies and guidelines, the expansion of laboratory networks, and the improvement of laboratory infrastructure and equipment. ASLM's experience highlights the importance of laboratory medicine in public health and demonstrates the impact of collaborative efforts in advancing health outcomes in Africa.
Zawya
10 hours ago
- Zawya
Canadian University Dubai to lead three DFF funded projects to advance healthcare innovation
Dubai, UAE: Researchers from the Canadian University Dubai (CUD) have been awarded three separate grants from the Dubai Future Foundation (DFF) Research, Development, and Innovation (RDI) Program to advance the application of technologies to improve the health of people in the UAE. CUD faculty will be leading each of the projects, that will develop tools to improve health outcomes and position the UAE at the forefront of technology-driven healthcare solutions. The university's School of Engineering, Applied Science and Technology has secured two grants to support projects aimed at advancing technologies that support diagnostic and therapeutic aspects of healthcare. Led by CUD's Prof. Firuz Kamalov, in collaboration with the Abu Dhabi School of Management and the University of Huddersfield, a team of researchers will pioneer an Explainable Artificial Intelligence system to support the early detection of dementia and to develop an understanding of its potential progression. The project has the capacity to deliver a major step forward in transforming dementia care through AI-driven innovation that can deliver earlier diagnosis to improve patient treatment, guide clinical decisions, and offer vital support to families. Meanwhile, another project in the same School of Engineering Applied Science and Technology is led by Associate Professor, Dr. Haythem El-Messiry, in partnership with researchers from Shandong University and the Mohamed bin Zayed University of Artificial Intelligence. This project will harness the power of Volume Electron Microscopy (VEM) to enhance biological research capabilities. VEM involves a group of electron microscopy techniques for revealing the 3D ultrastructure of organisms at nanometer resolution. The technology is heralded as a revolutionary advancement in imaging to unravel biological complexity at scale, supporting the progression of research in health sciences. This project aims to develop a fast, robust, and high-precision VEM image processing workflow which can achieve high-throughput and high-resolution large-scale biological 3D structure analysis to effectively bridge the gap between cell biology and tissue biology analysis. A third project in the university's School of Health Sciences and Psychology will embark on a pioneering project to establish a Health Technology Assessment (HTA) System in the UAE, to improve evidence-based decision-making in healthcare. Aiming to digitize health systems and promote multi-sectoral and multidisciplinary approaches, the project will integrate AI and web-based platforms, to enable more informed decisions about the value and reimbursement of health technologies. Led by CUD Assistant Professor, Dr. Mohammed AlKhaldi, the research team will also include CUD Associate Professor, Dr. Wissam Ghash, along with collaborators from McGill University, Canada and University of Bonn, Germany. Each of the projects aims to contribute to the UAE's strategic vision to be a world leader in healthcare and wellbeing. Speaking about the awards, CUD Provost, Dr. Adam Fenech said, 'These grants recognize CUD's leading role in health research and innovation in the UAE and wider region. With the support of Dubai Future Foundation and our institutional partners, we are tackling critical issues in global healthcare. These projects have the potential to establish the UAE as the benchmark for innovations that have impact on a global scale.' About Canadian University Dubai Established in 2006, Canadian University Dubai (CUD) is a higher education institution located in City Walk, Dubai, United Arab Emirates (UAE). The university is the #1 ranking University in Dubai according to the QS World University Rankings 2025. CUD is a diverse and dynamic institution, with over 120 student nationalities. With a reputation for academic excellence, the university offers more than 30 specialized majors, concentrations, and focus area pathways, through over 25 accredited undergraduate and graduate degree programs. The curriculum is Canadian-inspired and serves as a gateway for students to pursue higher education, research, entrepreneurship and employment opportunities in Canada.
Zawya
a day ago
- Zawya
Dubai Health, GE HealthCare to enhance Point-of-Care Ultrasound education, practice in MENA region
Dubai Health and GE HealthCare, a leading global medical technology and digital solutions innovator, have signed a Memorandum of Understanding (MoU) to collaborate on enhancing Point-of-Care Ultrasound (POCUS) practices and co-developing innovative AI solutions to support clinical decision-making, ultimately enhancing patient care and outcomes across the UAE and the Middle East and North Africa (MENA) region. The collaboration combines Dubai Health's academic and innovation expertise with GE HealthCare's advanced technological capabilities to enhance medical education, strengthen clinical decision-making, and improve health outcomes throughout the UAE and the broader MENA region. The MoU will establish Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) as a POCUS Education Center of Excellence and a pioneer in Point-of-Care Ultrasound education across the MENA region. Key initiatives include: a 'Train-of-Trainer (TOT)' structured program to build capacity in certified facilitators and trainers. The Facilitator Training Program will also enhance the scalability and effectiveness of POCUS programme delivery and execution across a broader geographical region, enabling wider participation of attendees, students, and delegates. In addition, the collaboration will extend to the co-development of AI solutions through Dubai Health Innovations, which supports transformative solutions that enhance patient care, drive medical advancements, and improve health outcomes. This partnership will focus on the development and validation of emerging AI technologies in areas of mutual interest, such as radiology and computer vision, aiming to improve diagnostic accuracy, streamline clinical workflows, and facilitate early detection of medical conditions. Through this joint effort, both parties seek to foster innovation, accelerate adoption of cutting-edge AI tools, and contribute to the advancement of healthcare delivery in the region. Dr. Hanan Al Suwaidi, Acting Chief Academic Officer of Dubai Health and Provost of MBRU said, 'This collaboration reflects Dubai Health's commitment to delivering on our 'Patient First' promise through the integration of care, learning, and innovation to elevate healthcare standards. By building capacity in POCUS education and co-developing AI-powered solutions, we are empowering clinicians with next-generation technologies to improve patient outcomes.' President of GE HealthCare EAGM (Eurasian and African Growth Markets), Konstantinos Deligiannis, said, 'This MoU marks a pivotal moment for POCUS advancement in the MENA region. We are excited to partner with Dubai Health to build skills, accelerate knowledge transfer, and strengthen the local and regional healthcare expertise. By combining our advanced ultrasound technology with innovative AI solutions, we are committed to enhancing diagnostic accuracy and efficiency, ultimately contributing to the region's broader healthcare objectives.' Dr. Rasha Buhumaid, Vice Dean of Graduate Medical Education, Assistant Professor of Emergency Medicine, and Programme Director of POCUS at MBRU, further commented, 'This partnership is a significant step toward realising our vision of positioning MBRU as a Centre of Excellence for Point-of-Care Ultrasound education. Through the Facilitator Training Programme and other initiatives, this collaboration enables us to strengthen the integration of POCUS into clinical practice, build sustainable expertise, and support better outcomes at the point of care and across the health system.' Professor Nabil Zary, Senior Director of the Institute of Learning at Dubai Health, also noted, 'Education is at the heart of sustainable healthcare transformation. This partnership with GE HealthCare enables us to deliver high-impact, evidence-based training in POCUS that not only equips clinicians with advanced skills but also fosters a culture of continuous learning and innovation.' The MoU between the two parties will be in effect for two years and is renewable by mutual agreement.
